A Study to Evaluate Drug-drug Interactions Between BR1017-1 and BR1017-2 in Healthy Volunteers
- First Posted Date
- 2022-05-12
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 32
- Registration Number
- NCT05372380
- Locations
- đ°đ·
CHA Bundang Medical Center, CHA University, Gyeonggi-do, Seongnam-si, Korea, Republic of
A Clinical Trial to Compare the Pharmacokinetics and Safety of "BR1016A" With "BR1016B" in Healthy Volunteers
- First Posted Date
- 2021-11-02
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 60
- Registration Number
- NCT05102903
- Locations
- đ°đ·
Metro Hospital, Anyang, Korea, Republic of
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2021-11-01
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 100
- Registration Number
- NCT05102305
- Locations
- đ°đ·
The Konkuk University medical center, Seoul, Korea, Republic of
A Clinical Trial to Compare the Pharmacokinetics and Safety of "BR1016C" With "BR1016D" in Healthy Volunteers
- First Posted Date
- 2021-11-01
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 60
- Registration Number
- NCT05102266
- Locations
- đ°đ·
Bestian Hospital, Osong, Korea, Republic of
A Clinical Trial to Evaluate Drug-drug Interactions and Safety Between "BR1015-1" and "BR1015-2" in Healthy Volunteers
Phase 1
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2021-10-28
- Last Posted Date
- 2021-11-22
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 31
- Registration Number
- NCT05097794
- Locations
- đ°đ·
CHA Bundang Medical Center, CHA University, Gyeonggi-do, Seongnam-si, Korea, Republic of
An Observation Study to Evaluate the Renoprotective Effect of Fimasartan in Patients With DKD and Proteinuria
Completed
- Conditions
- ProteinuriaDiabetic Kidney DiseaseHypertension,Essential
- First Posted Date
- 2021-10-21
- Last Posted Date
- 2023-07-12
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 360
- Registration Number
- NCT05086549
- Locations
- đ°đ·
Severance hospital, Yonsei University Health System, Seoul, Korea, Republic of
A Clinical Trial to Compare the Pharmacokinetics and Bioequivalence of "BR2008" With "BR2008-1" in Healthy Volunteers
Phase 1
Completed
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Drug: BR2008-1 (R)Drug: BR2008 (T)
- First Posted Date
- 2021-10-05
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 57
- Registration Number
- NCT05068193
- Locations
- đ°đ·
Bestian Hospital, Osong, Korea, Republic of
A Study to Compare the Pharmacokinetics and Safety Between BR9004 and BR9004-1 in Healthy Male Volunteers
- First Posted Date
- 2021-05-17
- Last Posted Date
- 2021-07-22
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT04889651
- Locations
- đ°đ·
CHA Bundang Medical Center, CHA University, Gyeonggi-do, Seongnam-si, Korea, Republic of
A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
Phase 3
Completed
- Conditions
- Type2 Diabetes
- Interventions
- First Posted Date
- 2021-05-13
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 378
- Registration Number
- NCT04885712
- Locations
- đ°đ·
Asan Medical Center, Seoul, Korea, Republic of
A Multi Doses Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Smoking Cessation
- Interventions
- Drug: BR9003 2mgDrug: BR9003A 1mg
- First Posted Date
- 2021-04-23
- Last Posted Date
- 2021-08-18
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 27
- Registration Number
- NCT04857047
- Locations
- đ°đ·
Inha University Hospital, Incheon, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath